KMTS · Kestra Medical Technologies, Ltd.

Track KMTS — free

$28.02 +0.28 (+1.01%) At close · Aug 14

Market Cap

$1.64B

58.60M

Up next

Next earnings call

Oct 16, 2026 Est · unconfirmed · in 9 wks

FQ2-27 quarter ends

~Oct 30, 2026 Est

Latest filing: 10-K

filed Jul 14, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Strong Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 14.3 · calm Equity put/call 0.52

Technical

price trend

Strong Buy

50 / 200-day cross Golden cross

Price vs 200-day avg +19%

above

Price vs 50-day avg +18%

above

RSI (14) 64

neutral

MACD trend Positive

52-week position 97%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return +15%

trailing

6-month return +5%

trailing

YTD return +6%

this year

Relative strength −9%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) Golden cross

50d $24 › 200d $24 — 50d above 200d

Institutional flow Accumulating

+6% holders QoQ · +17 funds added

Insider flow Distributing

Net -$4.1M over 90 days · 100% sells

Short interest Rising

5.62% of float · ▲ +6.4% MoM · 10.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

109 holders — near 1-yr high, broad support

Squeeze score 83

high risk · 0–100

Fundamentals

Excellent

Revenue growth +59%

Y/Y

Gross margin 51%

expanding

EPS growth +53%

Y/Y

Free cash flow $-116.6M

Balance sheet $57.1M

net cash

Quant / Vol

risk profile

Very High

Volatility 67%

annualized · 1-yr

Max drawdown −36%

past year

ATR 5.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Jul 14, 2026

Revenue · FY27 $137M

Prior guidance period ended · from the 8-K filed Mar 17, 2026

FY26 revenue guidance · FY26 $93M

Guided vs delivered · last 1 settled

FY26 revenue FY26

guided $91M

guided $91M $95.13M Beat +4.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy

0 · 2 · 5

50 / 200-day cross

Golden cross Bullish

Price vs 200-day avg

+19% Bullish

Price vs 50-day avg

+18% Bullish

RSI (14)

64 Neutral

MACD trend

Positive Bullish

52-week position

97% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) Golden cross

50d $24 › 200d $24 — 50d above 200d

Institutional flow Accumulating

+6% holders QoQ · +17 funds added

Insider flow Distributing

Net -$4.1M over 90 days · 100% sells

Short interest Rising

5.62% of float · ▲ +6.4% MoM · 10.2 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

109 holders — near 1-yr high, broad support

Price context

position in its 52-week range

Range low $16 Now $28 · 97% Range high $28

vs 200-day avg +19% vs 50-day avg +18% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
prescriptions were written for the ASSURE® system	6,357	Q4 FY2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Instruments & Supplies — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
KMTS Kestra Medical Technologies, Ltd. this stock	$1.64B	+5.7%	+59.0%	—	5.6%
ISRG Intuitive Surgical Inc	$139.37B	-30.3%	+20.5%	45.3	1.9%
BDX Becton Dickinson & Co	$49.96B	—	+8.2%	—	3.7%
MDLN Medline Inc.	$46.99B	-14.9%	+11.5%	—	2.6%
ALC Alcon Inc	$35.89B	-5.8%	+10.5%	—	2.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

109

% held: 100.2%
Net QoQ: +271.0K sh
Top holder: Bain Capital Investors LLC

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

3.3M

Days to cover: 10.2d
Change: +197.8K sh

View

Short Volume

Short vol %

50%

As of: Aug 14, 2026

Short Total

View

Fails to Deliver

FTD shares

6.9K

Value: $171.2K
As of: Jul 14, 2026

View

Off-Exchange

Off-exchange %

41.2%

Week of: Jul 6, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$4.1M

Buyers / Sellers: 0 / 5

Buyers Sellers

View

Financials

Revenue (FY)

$95.1M

Net income (FY): $-131.6M
EPS diluted: $-2.43

View

Filings

SEC Filings

Latest

DEF 14A

Filed: Jul 28, 2026
This year: 5

View

Proposed Sales

Value

$680.4K

Shares: 26.3K
Filed: Aug 7, 2026

View

Earnings & Events

Earnings Calls

Last call

Jul 14, 2026

View

Investor Relations

Upcoming events

View

Performance

	5D	20D	120D	MTD	YTD
KMTS	+6.1%	+14.7%	+5.0%	+22.7%	+5.7%
SPY	+0.4%	+4.5%	+13.8%	+3.9%	+13.9%
vs SPY	+5.7%	+10.3%	-8.8%	+18.8%	-8.2%

Key facts CIK 1877184 CUSIP G52441105 13F (30d) 109 filings 107 filers Visit website Investor relations

KMTS · Kestra Medical Technologies, Ltd.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance